CONSHOHOCKEN, Pa. -- Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that WIL Research has placed an expanded order for the deployment of a comprehensive solution to optimize study-related processes at all WIL Research worldwide sites.
Following the recent completion of a thorough vendor evaluation, Instem was chosen by WIL Research for its market leadership position, global support capabilities, product functionality and strong endorsements from existing Instem clients.
Following an announcement earlier this year about the project, WIL Research has now turned to Instem for an expanded role in their multi-year global harmonization project as they look to provide a consistent experience for their clients around the world.
"Instem's solution will provide exactly what we need; harmonized data collection, integrated scheduling, cutting edge SEND management tools and support for our global reporting to enable improved decision making across all of our departments," commentsDavid Spaight, CEO at WIL Research. "I'm confident that our expanded technology investment will enrich our research processes, help develop better controls and provide excellent experiences for every one of our clients, while expanding our capabilities for continued growth."
WIL Research has approximately 1,300 staff and 63,000 square meters of laboratory space around the world. Their facilities offer a blend of technical and regulatory expertise in discovery support, product safety toxicological research, metabolism, bioanalytical chemistry, analytical chemistry, formulation and regulatory services.
"We are looking forward to delivering tangible business impact for WIL Research as their premier preclinical technology partner through this transformational program," states Gregor Grant, Senior Vice President at Instem. "We are impressed by WIL's commitment to create more value for their clients through these enhancements and as the leading provider of SEND solutions, with more than 30 licensed sites in 11 countries, we are especially encouraged to see WIL supporting a critical FDA-adopted CDISC standard in preclinical."
The WIL Research program has been developed to harmonize global systems and processes that will effectively create a single hosted environment providing better efficiencies with more controls for them and their clients. Instem will additionally be assisting WIL Research reduce the amount of paper-based data, and using Instem's powerful 21 CFR part 11 compliant Logbook™ ELN technology, WIL Research will be moving toward paperless processes which will further drive increases in productivity and quality.
WIL Research will be using Instem's hosting services, globally. Instem's professionally managed hosted platforms are run from centralized state-of-the-art data centers, which are being used by clients running GLP and non-GLP studies around the world.
About WIL Research
WIL Research is an interdisciplinary non-clinical contract research organization providing product safety, toxicological assessment research, bioanalytical, regulatory compliance / registration, formulation and manufacturing services to the international pharmaceutical, biotechnology, veterinary, industrial and agricultural chemical industries.
Find out more about WIL Research at www.wilresearch.com
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations inIndia and a full service distributor based in Japan.
To learn more about Instem solutions and its mission, please visit www.instem.com.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600
Kara Turtinen, Account Executive
730 West Randolph, 5th Floor
Chicago, IL 60661
+ 1-312-997-2436 | Main
+ 1-715-456-0057 | Cell